Related Experiment Video
Updated: Jul 9, 2026
05:59
High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Nonpharmacologic therapy for insomnia in the elderly
1Bettendorf Internal Medicine and Geriatrics, 4480 Utica Ridge Road, Suite 160, Bettendorf, IA 52722, USA. seemajoshi@hotmail.com
Clinics in Geriatric Medicine
|November 24, 2007
Summary
Nonpharmacologic treatments, including cognitive behavior therapy, effectively manage insomnia in older adults. These drug-free approaches offer a well-suited clinical option for improving sleep in the elderly.
Area of Science:
- Gerontology
- Sleep Medicine
- Behavioral Science
Background:
- Insomnia is a prevalent sleep disorder affecting the elderly population.
- Pharmacologic treatments carry risks and may not be ideal for long-term management in older adults.
Purpose of the Study:
- To review the efficacy and suitability of nonpharmacologic interventions for insomnia in the elderly.
- To highlight common cognitive behavior therapy (CBT) techniques used in this population.
Main Methods:
- Review of evidence-based nonpharmacologic treatment modalities for insomnia.
- Focus on behavioral, cognitive, and physiologic interventions.
- Inclusion of specific cognitive behavior therapy for insomnia (CBT-I) components.
Main Results:
- Nonpharmacologic treatments demonstrate effectiveness in managing insomnia among the elderly.
- These methods can be used as standalone therapies or adjuncts to pharmacologic treatment.
- Specific CBT-I techniques like stimulus control, sleep restriction, and sleep hygiene are key components.
Conclusions:
- Nonpharmacologic therapies are effective and appropriate for the clinical management of insomnia in older adults.
- These approaches offer a safe and sustainable alternative or complement to medication for geriatric insomnia.
Related Concept Videos
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...